World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
30431
World Ranking
14490
National Ranking
557

Overview

Fabrizio Stocchi is affiliated with San Raffaele University of Rome in Italy and has an extensive publication record in the fields of medicine and neuroscience. Their research primarily focuses on neurology, with significant contributions to cognitive neuroscience and psychiatry and mental health. Subfields of interest also include cellular and molecular neuroscience as well as physiology.

The scientist's recent publications cover a range of topics related to neurological diseases and treatments. Notable papers include:

  • Trial of Prasinezumab in Early-Stage Parkinson's Disease, 2022, New England Journal of Medicine
  • Trial of Cinpanemab in Early Parkinson's Disease, 2022, New England Journal of Medicine
  • Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals, 2023, Movement Disorders
  • Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel, 2021, Alzheimer s & Dementia
  • Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease, 2023, European Journal of Neurology

Their main topics of work encompass Parkinson's Disease mechanisms and treatments, neurological disorders and treatments, EEG and brain-computer interfaces, functional brain connectivity studies, neural dynamics and brain function, botulinum toxin and related neurological disorders, and autism spectrum disorder research.

Frequent co-authors collaborating with Stocchi include Claudio Babiloni, Raffaele Ferri, Claudio Del Percio, Roberta Lizio, and Giuseppe Noce.

The primary venues where their work is often published include Parkinsonism & Related Disorders, Alzheimer s & Dementia, Neurology, Frontiers in Neurology, and Movement Disorders Clinical Practice.

Best Publications

  • The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

    Paolo Barone;Angelo Antonini;Carlo Colosimo;Roberto Marconi

  • International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease : The NMSQuest study

    Kallol Ray Chaudhuri;Pablo Martinez-Martin;Anthony H.V. Schapira;Fabrizio Stocchi

  • The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

    Kallol Ray Chaudhuri;Pablo Martinez-Martin;Richard G. Brown;Kapil Sethi

  • A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

    C. Warren Olanow;Olivier Rascol;Robert Hauser;Paul D. Feigin

  • Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

    O Rascol;DJ Brooks;E Melamed;W Oertel

  • Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

    Pablo Martinez-Martin;Anthony H.V. Schapira;Fabrizio Stocchi;Kapil Sethi

  • A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.

    Alessio Di Fonzo;Alessio Di Fonzo;Christan F Rohé;Joaquim Ferreira;Hsin F Chien

  • Factors that impact on quality of life in Parkinson's disease: results from an international survey

    L. Findley;T. Eichhorn;Aleksandar Janca;J. Kazenwadel

  • Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications

    C Warren Olanow;Jose A Obeso;Fabrizio Stocchi

  • Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease: Risk Factors forL-Dopa Induced Motor Complications

    C. Warren Olanow;Karl Kieburtz;Olivier Rascol;Werner Poewe

  • Levodopa in the treatment of Parkinson's disease: current controversies.

    C. Warren Olanow;Yves Agid;Yoshi Mizuno;Alberto Albanese

  • The Nondeclaration of Nonmotor Symptoms of Parkinson's Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire

    K. Ray Chaudhuri;Cristina Prieto-Jurcynska;Yogini Naidu;Tanya Mitra

  • Validation of the Freezing of Gait Questionnaire in patients with Parkinson's disease

    Nir Giladi;Joseph Tal;Tali Azulay;Oliver Rascol Md

  • Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.

    Fabrizio Stocchi;Olivier Rascol;Karl Kieburtz;Werner Poewe

  • ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

    A. Di Fonzo;H. F. Chien;M. Socal;S. Giraudo

  • Early-onset parkinsonism associated with PINK1 mutations Frequency, genotypes, and phenotypes

    V. Bonifati;C. F. Rohé;G. J. Breedveld;E. Fabrizio

  • Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease

    R. Pahwa;M. A. Stacy;S. A. Factor;K. E. Lyons

  • Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease: A Clinical and Pharmacokinetic Study

    Fabrizio Stocchi;Laura Vacca;Stefano Ruggieri;C. Warren Olanow

  • Levodopa in the treatment of Parkinson's disease: a consensus meeting.

    Y. Agid;E. Ahlskog;A. Albanese;D. Calne

  • ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson's disease

    A Di Fonzo;H Chien;M Socal;S Giraudo

Frequent Co-Authors

Angelo Antonini
Angelo Antonini University of Padua
Claudio Babiloni
Claudio Babiloni Sapienza University of Rome
Roberta Lizio
Roberta Lizio Sapienza University of Rome
Raffaele Ferri
Raffaele Ferri I.R.C.C.S. Oasi Maria SS
Stefano Ruggieri
Stefano Ruggieri Sapienza University of Rome
Marco Onofrj
Marco Onofrj University of Chieti-Pescara
Pablo Martinez-Martin
Pablo Martinez-Martin Instituto de Salud Carlos III
C. Warren Olanow
C. Warren Olanow Icahn School of Medicine at Mount Sinai
Andrea Soricelli
Andrea Soricelli Parthenope University of Naples
Giovanni Fabbrini
Giovanni Fabbrini Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in alternative or complementary career paths to studying Medicine in the USA, there are a variety of online healthcare degrees offering flexibility and specialization. Many professionals pursue administrative roles through cahme accredited mha online programs, which provide advanced training in healthcare management and leadership. This option is ideal for those who want to impact the healthcare system beyond clinical practice.

If you are a registered nurse seeking career advancement, consider an rn to bsn online with no clinicals program. These flexible programs let you earn your bachelor's degree without the need for additional in-person clinical hours, making it more convenient for working nurses.

Those aiming for the highest levels of clinical leadership can explore 1 year dnp program online options. These accelerated programs provide a fast track to a Doctor of Nursing Practice degree. Additionally, for those looking for accessible options, several institutions offer easiest dnp programs designed to reduce barriers without sacrificing educational quality.

Best Scientists Citing Fabrizio Stocchi

Trending Scientists

Recently Published Articles